RecallWatchUSA

Home / Categories / Drugs

Drugs Recalls

17,897 recalls, newest first.

November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone / Triamcinolone Acetonide Pellet (200MG/40MCG), 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, Far
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone / Triamcinolone Acetonide Pellet (100MG/20MCG), 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, Far
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone / Triamcinolone Acetonide 87.5MG/17.5MCG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone / Triamcinolone Acetonide, 62.5MG/12.5MCG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKei
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone / Triamcinolone Acetonide 50MG/10MCG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Out
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone / Triamcinolone Acetonide Pellet (37.5MG/7.5MCG), 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, F
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone / Triamcinolone Acetonide 25MG/5MCG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outs
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone / Triamcinolone Acetonide, 12.5MG/2.5MCG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone Regular Release 200 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone Regular Release 50 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone 200 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, S
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone 87.5 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave,
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone 62.5 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave,
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone 50MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
FARMAKEIO OUTSOURCING LLC recalls Testosterone 25MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste
Hazard: CGMP Deviations: Potential presence of metal particulate matter
November 5, 2025DrugsFDA
ACME UNITED CORPORATION recalls Sting Relief Swabs, First Aid Only, 10 Swabs per box, part number 19-001, Manufactured for: Acme United Corporation, 1 W
Hazard: Product Mix-up
November 5, 2025DrugsFDA
Kenvue Brands LLC recalls TYLENOL, Acetaminophen, Extra Strength, 24 Caplets, 500mg each, distributed by: Johnson & Johnson Consumer Inc., McNeil
Hazard: Defective Container
November 5, 2025DrugsFDA
ProRx LLC recalls Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffe
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeff
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Je
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Je
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jef
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
ProRx LLC recalls Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffe
Hazard: Lack of Assurance of Sterility
November 5, 2025DrugsFDA
QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Vo
Hazard: Presence of Particulate Matter
November 5, 2025DrugsFDA
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 150 mg, 50 count bottle (NDC 23155-583-25), Rx only, Manufactured by: USV Privat
Hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
November 5, 2025DrugsFDA
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 100 mg, 100 count bottle (NDC 23155-582-01), Rx only, Manufactured by: USV Priva
Hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
November 5, 2025DrugsFDA
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 75 mg, 100 count bottle (NDC 23155-581-01), Rx only, Manufactured by: USV Privat
Hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
November 5, 2025DrugsFDA
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 50 mg, 100 count bottle (NDC 23155-580-01), Rx only, Manufactured by: USV Privat
Hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
November 5, 2025DrugsFDA
Heritage Pharmaceuticals Inc recalls Desipramine Hydrochloride Tablets, USP, 25 mg, 100 count bottle (NDC 23155-579-01), Rx only, Manufactured by: USV Privat
Hazard: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.